Mumbai: Conducted every year, this flagship conference by The Society for Pharmaceutical Dissolution Science (SPDS) is attended by Pharmaceutical R&D, QA, and QC as well as academia professionals from India & abroad, involving speakers from the US, Europe, and Asia. This year, due to the Covid-19, pandemic, the International Conference is being conducted online in collaboration with AAPS, USA, and conducting the event jointly from 24- 26 June 2021 (15.00 hrs to 20.00 hrs, IST)
The theme of the event is “Dissolution as a Pivotal Tool for Drug Product Performance”. The Society for Pharmaceutical Dissolution Science (SPDS), an organisation which was formed only 9 years back and has gained international presence and acceptance in a short span of time.
Disso India- 2021 Online will have around 18 to 20 lectures from eminent professionals working in the pharmaceutical industry from around the world as well as academia coupled with panner discussion. Over five thousand professionals from Pharma R&D, QA, QC, and Academia across the Globe are expected to register for this unique event to discuss various advances and developments related to dissolution science and its applications. The event is Organised by its President -Mr. Vijay Kshirsagar, Vice president, Dr. Padma Devarajan & General secretary Dr.L. Ramaswamy and the organising committee members (www.spds.in)
The scientific sessions are programmed and executed under the Chairmanship of Professor Arvind Bansal, Head-Department of Pharmaceutics, NIPER, SAS Nagar, and the Co-Chair-Dr.Vinod P Shah, Ex-US FDA and Pharmaceutical Consultant, USA.
A galaxy of eminent speakers will enlighten the attendees on current dissolution-centric technologies and sciences.
Below are the lectures that will be a part of Disso India 2021 Online:
• AAPS Role in Advancement of Pharmaceutical Science
Dr. Tina Morris, Chief Executive Officer, AAPS, USA
• The Role of Dissolution in the Development of Complex Generics Including Topical/Ophthalmic Drug Products
Dr. Vinod P Shah, Ex-USFDA, Pharmaceutical Consultant, USA
• Solubility - Permeability Interplay in the Dissolution
Dr. Vatsala Nageshwaran, Chief Business Officer, Absorption Systems, USA
• Cocrystals for Solubility Enhancement
Prof. Arvind Bansal, Professor & Head, Department of Pharmaceutics, NIPER, SAS Nagar, India
• Excipients for Enabling Technologies
Dr. Sandip Tiwari, Head of Technical Services - Pharma Solutions, North America, BASF, USA
• USP Apparatus 4 as a Biowaiver Tool for Specialized Formulations
Samir Haddouchi, Managing Director, SPS Pharma Services, Orleans, France
• Nanosystems: Dissolution Methodologies and Biorelevant Media
Prof. Padma Devarajan, Dean-Research & Innovation and Professor in Pharmacy, Institute of Chemical Technology, India
• Intelligent vs Intellectual vs Regulatory Compliant Dissolution Testing: Where do we Draw the Lines!!
Dr. Umesh Banakar, Professor and President, Banakar Consulting Services, USA
• Scientific Pursuit for Improving Human Health
Dr. Andrew Vick, President, AAPS, USA
• Physiologically Based Absorption Modelling (PBAM)
Dr. Sandra Suarez-Sharp, Vice President of Regulatory Affairs, Simulations Plus Inc., USA
• Relevance of Intrinsic Dissolution Testing
Vijay Kshirsagar, CEO & President, TRAC Consulting, India
• Bio predictive Dissolution Methods
Dr. Deanna Mudie, Lonza Inc, USA
• Clinically Relevant Dissolution Specifications/Patient-Centric Dissolution Testing
Dr. Andreas Abend, Director in the Analytical Sciences Group, Merck, USA
• Advances in Dynamic Dissolution
Mark McAllister, Senior Scientific Director, Pfizer, USA
• Automation for Dissolution Data Integrity
Jürgen Kempf, Business Development Manager Automation, SOTAX AG, Switzerland
• Hydrodynamics in Dissolution Apparatus (Role of Designing of Dissolution Vessel)
Dr. Deirdre D’Arcy, Associate Professor, Trinity College, Ireland
• Automated, Pharmacopeia-compliant UV/V is spectrometer calibration for dissolution testing
Dr. Hans-Joachim Muhr, Head of Strategic Product Group UV/VIS Scientific Director, Mettler-Toledo GmbH, Analytical, Switzerland
• PIV measurements of USP Apparatus 1 Hydrodynamics – A closeup story
Dr. Satish Perivelli, Senior Scientist II, Dosage form performance laboratory USP, USA
• Influence of Particle Characteristics on Dissolution Testing
Sandeep Kulkarni, Scientific Director, Image Provision Technology Pvt. Ltd., India
A Registered NGO, Society for Pharmaceutical Dissolution Science (SPDS) was formed on 16th July 2012 in Mumbai with the objective of promoting Science and Technological Development in the field of Dissolution Science among pharmaceutical professionals, Academia, Students, Regulatory Bodies, etc. SPDS is the only professional body dedicated to Dissolution and its application worldwide. SPDS envisions to be one of the most prominent organizations focusing on Dissolution Science among the Pharmaceutical Industry and Academia.
SPDS is proud to have partnered with the American Association of Pharmaceutical Scientists (AAPS) for this year's Disso India 2021 event. Founded in 1986, the American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 7,000 individual members and over 10,000 actively participating stakeholders employed in academia, industry, government, and other pharmaceutical science-related research institutes worldwide. The mission of AAPS is to "Advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health". It works on five core values - Learning, Innovation, Service, Inclusiveness, and Integrity.
While talking with Dr. Prakash Bhosale a media representative with SPDS General secretory & MD of SOTAX India Dr. L. Ramaswamy appealed to Pharmaceutical Industry & Healthcare Academia in India & Abroad to join this online conference & make it a success and enhance the quality of drugs produced by Pharma Companies.
Media Contact
Dr. Prakash Bhosale
BBG EBRANDING MEDIA
Email: -
[email protected]